GCG and Hypoglycemia: Remarkably, the MTII treatment improved counterregulatory responses to hypoglycemia (Figure 6F) in the diabetic mice by augmenting the stimulation of epinephrine and glucagon release (Figure 6G) compared to the diabetic mice that received PBS.